ClinConnect ClinConnect Logo
Search / Trial NCT03268109

COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old

Launched by FONDATION OPHTALMOLOGIQUE ADOLPHE DE ROTHSCHILD · Aug 29, 2017

Trial Information

Current as of June 26, 2025

Completed

Keywords

ClinConnect Summary

This clinical trial is studying cognitive impairment, or memory problems, in older adults aged 65 and over who are living with HIV. Researchers want to understand how common these memory issues are in this age group since many people with HIV are getting older. The goal is to find ways to identify and help those who may experience difficulties in daily tasks or work because of cognitive impairment, even though they are being treated for HIV.

To participate in the study, individuals need to be between 65 and 80 years old, speak French, and have some concerns about their memory, either personally or from family members. They must also have a stable HIV condition with a low viral load for over a year. Participants will undergo assessments to better understand their cognitive health. It’s important to note that people with certain recent health problems or those who cannot have an MRI scan will not be eligible for this trial. This study is currently looking for participants, and joining could help contribute to better understanding and support for older adults living with HIV.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Personal or familial cognitive complaints
  • Individual aged ≥ 65 years old and \< 81 years old
  • Instrumental activities of daily living (IADL) score between 3-4
  • French speaking individual
  • Informed consent signed For PLHIV
  • HIV infection
  • Undetectable HIV viral load ≥ 1 year
  • Current cluster of differentiation (CD4) cell count \> 100/mm3 For controls
  • negative HIV serology ≤ 6 months
  • Exclusion Criteria:
  • Opportunistic infection \< 5 years
  • Contraindications to MRI

About Fondation Ophtalmologique Adolphe De Rothschild

The Fondation Ophtalmologique Adolphe de Rothschild is a leading French institution dedicated to advancing ophthalmic research and patient care. Renowned for its commitment to innovation in eye health, the foundation conducts cutting-edge clinical trials aimed at improving treatments for various ocular conditions. With a multidisciplinary team of experts, the foundation collaborates with academic and industry partners to enhance understanding of eye diseases and develop novel therapeutic solutions, ultimately striving to improve patient outcomes and quality of life in ophthalmology.

Locations

Paris, , France

Patients applied

0 patients applied

Trial Officials

Antoine Moulignier, MD

Principal Investigator

Fondation Ophtalmologique A. de Rothschild

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials